Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Mobix Labs, Inc. (MOBX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a fabless semiconductor and connectivity issuer listed on The Nasdaq Capital Market. Through these documents, investors can review how Mobix Labs reports on its RF, connectivity, interconnect and EMI filtering business, its capital structure and its financing activities.
Current and periodic reports such as Form 8‑K detail material events, including at‑the‑market offering agreements, warrant exercise inducement transactions, debt and equity financings, Nasdaq minimum bid‑price notices and extensions, and amendments to outstanding warrants that affect classification of these instruments as equity or liabilities. Certain 8‑K and 8‑K/A filings also describe leadership changes and advisory roles, as well as legal proceedings related to alleged failures to fund agreed‑upon investments.
Registration statements on Form S‑1 and Form S‑3, along with their amendments, outline registered offerings of Mobix Labs’ Class A common stock and the use of proceeds the company identifies, such as working capital, general corporate purposes, growth initiatives and M&A strategy. These filings also provide background on the company’s fabless semiconductor model, RF and connectivity focus, and risk factors.
Annual and quarterly reports on Forms 10‑K and 10‑Q, when filed, give a broader view of Mobix Labs’ financial condition, including revenue, gross margin, operating loss and liquidity metrics, as well as segment and market discussions. Preliminary, unaudited financial information referenced in news releases is later finalized in these periodic reports.
On Stock Titan, Mobix Labs filings are updated in near real time from EDGAR. AI‑powered summaries help explain complex sections of 10‑K and 10‑Q reports, highlight key points from 8‑K disclosures, and make it easier to interpret warrant, debt and equity terms. Users can also review ownership and insider‑related information when available through Forms 3, 4 and 5 to understand equity incentives and changes in beneficial holdings.
Mobix Labs, Inc. reported a net loss of $10.1 million for the three months ended December 31, 2025, narrower than the $19.8 million loss a year earlier. Revenue fell to $1.9 million from $3.2 million, with both product and services sales declining.
Gross profit dropped to $0.6 million, and interest expense increased to $1.4 million as total debt reached $6.3 million. Despite lower operating expenses, especially stock-based compensation, the company ended the quarter with only $0.3 million in cash, prompting a going concern warning about its ability to meet obligations over the next year.
Stockholders’ equity improved to $4.7 million from a deficit at September 30, 2025, helped by share issuances and warrant reclassification. After quarter-end, Mobix raised approximately $5.1 million net through a public offering of 30 million Class A shares at $0.20 each and issued additional make-whole shares to a lender.
Mobix Labs CEO Philip Sansone filed a Form 4 showing an automatic tax-related sale of shares. On February 2, 2026, Sansone sold 87,025 shares of Mobix Labs Class A common stock at a weighted-average price of $0.188 per share in a transaction coded as a sale.
According to the disclosure, the shares were sold solely to cover taxes arising from restricted stock units that vested on January 31, 2026, under a pre‑set “sell to cover” election, meaning the trades were not discretionary. After this transaction, Sansone directly beneficially owned 1,848,816 shares of Mobix Labs.
Mobix Labs, Inc. insider activity is disclosed in a Form 144 notice covering planned sales of common stock. The filing shows an intention to sell 87,025 shares of common stock through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of
The seller, Philip Sansone, previously acquired 200,000 common shares on
Mobix Labs, Inc. received an amended Schedule 13G/A showing that Vernon Davis Grizzard III and Sage Hill Investors, LLC together beneficially own 3,142,857 shares of its Class A common stock, representing 4.9% of the class as of December 31, 2025.
The reporting persons have sole voting power over 3,142,857 shares and sole dispositive power over 1,642,857 shares, with no shared voting or dispositive power. They certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Mobix Labs.
Mobix Labs, Inc. filed Amendment No. 1 to its annual report for the year ended September 30, 2025 to add detailed Part III information on directors, executive officers, compensation, security ownership, related-party transactions and auditor fees that was previously expected to come from the proxy statement.
The filing describes a classified, mostly independent board, recent leadership changes including Philip Sansone becoming CEO, and sizeable equity awards and severance protections for co-founders and senior executives. It also outlines substantial RSU and option grants to non-employee directors, significant beneficial ownership stakes held by insiders and Armistice Capital, related-party financing and PIPE arrangements, broad indemnification protections, and PwC audit fees of
Mobix Labs, Inc. filed its annual report for the year ended September 30, 2025, detailing a small specialized player in advanced wireless and wired connectivity, RF, and EMI filtering for defense, aerospace, industrial and medical markets. The company expanded through its acquisitions of EMI Solutions in December 2023 and RaGE Systems in May 2024, broadening its interconnect and wireless systems portfolio.
Mobix reported operating losses of $37.7 million in 2025 and $46.4 million in 2024, with an accumulated deficit of $150.6 million as of September 30, 2025, and disclosed substantial doubt about its ability to continue as a going concern without new capital. As of March 31, 2025, the non‑affiliate market value of its common stock was about $30.5 million. The company relies heavily on a few customers, with Leidos Holdings representing roughly 50% of 2025 net revenue.
Mobix had 46 employees as of September 30, 2025 and 64,308,034 Class A and 2,004,901 Class B shares outstanding as of November 30, 2025. It operates in highly competitive semiconductor and interconnect markets, highlights a strategy centered on mmWave IC development and further acquisitions, and lists extensive risk factors including customer concentration, need for additional financing, material weaknesses in internal controls, and Nasdaq listing compliance risk.
Mobix Labs, Inc. insider Samini Keyvan reported equity award activity and a related share sale. On December 21, 2025, 333,333 Restricted Stock Units vested and converted into 333,333 shares of Class A Common Stock at a stated price of $0.00 per share. On January 5, 2026, Keyvan sold 211,672 shares of Class A Common Stock at a weighted average price of $0.3243 per share, with prices ranging from $0.32 to $0.328 per share. According to the disclosure, these shares were sold solely to satisfy tax withholding obligations from the RSU vesting under a pre-arranged sell-to-cover election and are not discretionary trades. Following these transactions, Keyvan directly beneficially owns 2,671,661 shares of Class A Common Stock, with additional indirect holdings through family trusts, and holds fully vested options covering 323,529 Class A shares.
Mobix Labs, Inc. is conducting a primary offering of up to 30,000,000 shares of Class A common stock at $0.20 per share, for gross proceeds of about $6.0 million. After placement fees and expenses, Mobix estimates net proceeds of approximately $5.135 million, which it plans to use for working capital and general corporate purposes.
The deal is a best-efforts offering through D. Boral Capital, with no minimum amount and no escrow; funds become immediately available to the company even if the maximum is not sold. Existing holders face immediate and substantial dilution, as the share count would rise from 64,308,034 to 94,308,034 Class A shares if the full amount is issued, and additional dilution could come from options, RSUs, warrants and earnout shares.
The company highlights going concern risks and the need for additional capital, and it is currently not in compliance with Nasdaq’s minimum bid price and market value listing standards, with an extension to regain compliance by April 27, 2026. Failure to comply could lead to delisting, which may reduce liquidity and make future financing more difficult.
Mobix Labs, Inc. entered into securities purchase agreements for a public offering of 30,000,000 shares of its Class A common stock at $0.20 per share.
The company engaged D. Boral Capital LLC as placement agent, agreeing to an 8.0% cash placement fee, up to 1.0% of gross proceeds for non-accountable expenses, and up to $100,000 for legal and other expenses. Net proceeds to Mobix Labs were approximately $5,135,000, which the company plans to use for working capital and other general corporate purposes. The company agreed to short-term restrictions on additional equity issuances and variable rate transactions, and its executive officers and directors entered 30-day lock-up agreements on their holdings following the closing.
Mobix Labs has a Form 144 notice indicating a planned sale of up to 211,672 shares of its Class A common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $68,654.56 and 58,620,000 shares outstanding.
The shares relate to 333,333 common shares acquired on 12/21/2025 through vesting of restricted stock units from Mobix Labs, with the transaction described as an RSU vest paid on that date.
FAQ
What is the current stock price of Mobix Labs (MOBX)?
What is the market cap of Mobix Labs (MOBX)?
